Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0TNQTB
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
DAC-1002
|
|||||
| Synonyms |
DAC-1002; DAC 1002; DAC1002; DXC-1002; DXC 1002; DXC1002
Click to Show/Hide
|
|||||
| Organization |
Hangzhou DAC Biotechnology Co., Ltd.
|
|||||
| Drug Status |
Phase 1
|
|||||
| Indication |
In total 1 Indication(s)
|
|||||
| Drug-to-Antibody Ratio |
Undisclosed
|
|||||
| Antibody Name |
Undisclosed
|
|||||
| Antigen Name |
Tumor-associated calcium signal transducer 2 (TROP2)
|
Antigen Info | ||||
| Payload Name |
CPT113
|
Payload Info | ||||
| Therapeutic Target |
DNA topoisomerase 1 (TOP1)
|
Target Info | ||||
| Conjugate Type |
Undisclosed
|
|||||
